(REGN:Consolidated Issue Listed on NASDAQ Global Select )
Robert E. Landry Jr.
Chief Financial Officer and Senior Vice President of Finance, Regeneron Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 3 different industries.|
As of Fiscal Year 2013
Mr. Robert E. Landry Jr., also known as Bob, Jr. has been Senior Vice President of Finance at Regeneron Pharmaceuticals, Inc since September 2013 and its Chief Financial Officer since October 1, 2013. Mr. Landry has responsibility for all financial functions, including Controller's, Treasury, Financial Planning, Tax, and Internal Audit. In his new role, Mr. Goldberg continue to have responsibility for Alliance Management and various administrative functions. He served ...
777 Old Saw Mill River RoadPhone: 914-347-7000
Tarrytown, New York 10591
Board Members Memberships*There is no Board Members Memberships data available.
University of Notre Dame
|Jean-Jacques Bienaimé||Chief Executive Officer and Director|
BioMarin Pharmaceutical Inc.
|Jeffrey M. Leiden M.D., Ph.D.||Chairman, Chief Executive Officer and President|
Vertex Pharmaceuticals Incorporated
|David E. I. Pyott||Chairman and Chief Executive Officer|
|Leonard Bell M.D.||Co-Founder, Chairman of the Board and Chief Executive Officer|
Alexion Pharmaceuticals, Inc.
|Frederic Roch Doliveux DVM||Chief Executive Officer and Executive Director|
|€2.1M||Compensation as of Fiscal Year 2013.|